FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 360:160-169 January 8, 2009 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text  Full Text Audio PowerPoint Slide Set CME Exam Supplementary Material Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the authors' clinical recommendations.

A healthy 25-year-old brunette woman reports a 12-month history of skin depigmentation. She first noticed patches of skin whitening on her hips; her physician prescribed an imidazole cream for a presumed fungal infection, but there was no improvement. After a vacation at the beach, she noticed additional depigmented patches on her elbows, shins, upper eyelids, and lower chin. A dermatologist made a . . . [Full Text of this Article]

The Clinical Problem

Strategies and Evidence

Evaluation

            Diagnosis

            Assessment

Treatment

            Ultraviolet Light

            Topical Therapies

            Surgery

            Other Therapies

Areas of Uncertainty

Guidelines

Conclusions and Recommendations

Source Information

From the Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Diseases, Centre Hospitalier Universitaire of Bordeaux, Bordeaux, France (A.T.); and San Gallicano Dermatological Institute, Rome (M.P.).

An audio version of this article is available at NEJM.org.

Address reprint requests to Dr. Taïeb at the Department of Dermatology, Hôpital Saint André, 1 rue Jean Burguet, 33075 Bordeaux, France, or at alain.taieb@chu-bordeaux.fr.

Related Letters:

Vitiligo
Naldi L., Sassi F., Taïeb A., Picardo M.
Extract | Full Text | PDF  
N Engl J Med 2009; 360:1788, Apr 23, 2009. Correspondence

This article has been cited by other articles:

• Quaglino, P., Marenco, F., Osella-Abate, S., Cappello, N., Ortoncelli, M., Salomone, B., Fierro, M. T., Savoia, P., Bernengo, M. G. (2009). Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study. Ann Oncol 0: mdp325v1-mdp325 [Abstract] [Full Text]  
• Naldi, L., Sassi, F., Taieb, A., Picardo, M. (2009). Vitiligo. NEJM 360: 1788-1788 [Full Text]  
• (2009). Vitiligo: A Practical Review. Journal Watch Dermatology 2009: 1-1 [Full Text]